Table 2. Effect of calpain inhibitors on axonal pathology in TBI and TAI models.
Model | Inhibitor(s) | Effect of Calpain Inhibitor(s) | Reference |
---|---|---|---|
Fluid shear stress; dissociated forebrain neurons |
ALLN (3 μM) | Reduces neurite beading (phase contrast microscopy) 60-90 min post-injury. |
Kilinc et al., 2009 |
Impact acceleration head injury |
MDL-28170 (30 mg/kg) IV 30 min before injury |
Reduces β-APP and RMO-14 immunostaining of axons in the corticospinal tract and medial longitudinal fasciculus at 2 h post-injury. |
Buki et al., 2003 |
Fluid percussion injury |
MDL-28170 IV (various dosing strategies) |
Inhibitor effect varies depending on dosing strategy and post-injury survival duration. Inhibitor reduces β-APP immunostaining in the corpus callosum. Although its effect on CAP is less consistent, inhibitor partially normalizes CAP amplitude and latency of first and second major peaks (corresponding to myelinated and unmyelinated axons, respectively). Amplitude correlates with number of axons generating action potentials, while latency represents velocity of action potential propagation. |
Ai et al., 2007 |
Controlled cortical impact |
ALLM IA bolus and infusion (total dose ~2.7 μmoles) |
Reduces axonal swellings, bulbs, and “breaks” in white matter tracts (NFL immunostaining) 24 h post-injury. |
Posmantur et al., 1997 |
Optic nerve stretch in vivo |
MDL-28170 IV bolus and infusion (total dose 67.5 mg/kg) |
No improvement in retrograde transport of Fluoro-gold 4 days post-injury. |
Ma et al., 2012a |
Optic nerve stretch in vivo |
Calpastatin overexpression |
Improves retrograde transport of Fluoro- gold 4 days post-injury. |
Ma et al., 2012b |
Impact acceleration head injury |
MDL-28170 (30 mg/kg) IV 30 min before injury |
Reduces the length, but not the thickness, of HRP-labeling of axons in the corticospinal tract 2 h post-injury. No effect observed in the medial longitudinal fasciculus. |
Czeiter et al., 2009 |
β-APP, β-amyloid precursor protein; CAP, compound action potential; HRP, horseradish peroxidase; NFL, neurofilament light; IA, intra-arterial; IV, intravenous